NSE filing, NSE: CARBORUNIV. Summary written from the filing by ALFA Finder's alert engine.
Carborundum Universal Ltd: key numbers
- Share price
- ₹1,086.10
- Market cap
- ₹20,691 Cr
- Revenue (annual)
- ₹5,206 Cr
- Net profit (annual)
- ₹194.7 Cr
- P/E (TTM)
- 98.9×Sector 52.2×
- Promoter holding
- 38.84%-0.05% QoQ
- FII holding
- 11.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Carborundum Universal Ltd
All →Carborundum Universal Other Announcement
Carborundum Universal Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting requirements.
Carborundum Universal Board Meeting Date
Carborundum Universal has scheduled a board meeting for November 2, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Carborundum Universal Other Announcement
Carborundum Universal Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, provided by its RTA, KFin Technologies Limited.
Carborundum Universal Employee Stock Options
Carborundum Universal Limited allotted 4,750 equity shares following the exercise of stock options under its ESOP Plan 2016.
Carborundum Universal Acquisition Worth ₹28.78 Cr
Carborundum Universal will invest ₹28.78 Crore in its wholly-owned subsidiary, CUMI International Limited. This capital infusion supports the closure of a German subsidiary.
- Value
- ₹28.78 Cr
Carborundum Universal Merger & Restructuring Worth ₹28.78 Cr
Carborundum Universal infused USD 3 million (approx. Rs. 28.78 Crore) into its wholly-owned subsidiary, CUMI International Limited, to fund its subsidiary's closure.
- Value
- ₹28.78 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.